Italy· 036334023
ACIDO VALPROICO*30 cpr 500 mg rilascio prolungato
A medicinal product containing acido valproico/sodio valproato, registered in Italy by SANDOZ SpA, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Acido valproico/sodio valproato
- Manufacturer
- SANDOZ SpA
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic036334023ACIDO VALPROICO*30 cpr 500 mg rilascio prolungatoEUR 8.17
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf58d6d4-26dd-419a-9092-bc4d1b697bb8 GET /v1/drugs/bf58d6d4-26dd-419a-9092-bc4d1b697bb8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 8.17,
"source": "aifa",
"currency": "EUR",
"strength": "ACIDO VALPROICO+SODIO VALPROATO 500MG 30 UNITA' USO ORALE RP",
"substance": "Acido valproico/sodio valproato",
"equivalence_group": "S2F",
"transparency_flag": null
}See everything about acido valproico/sodio valproato.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.